Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency

Clinical Endocrinology

Volumn 61, Issue 3, 2004, Pages 360-366

  Colao, Annamaria ^a   Di Somma, Carolina ^a   Filippella, Mariagiovanna ^a   Rota, Francesca ^a   Pivonello, Rosario ^a   Orio, Francesco ^a   Vitale, Giovanni ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FIBRINOGEN; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN C;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLE; DISEASE DURATION; DOPPLER ECHOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HUMAN; INSULIN BLOOD LEVEL; INTIMA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLE; THICKNESS; TUNICA MEDIA;

ADULT; AGED; BLOOD GLUCOSE; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FIBRINOGEN; GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; REGRESSION ANALYSIS; TUNICA INTIMA;

EID: 4644312361     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02105.x     Document Type: Article

References (37)

1. Bates, A.S., van't Hoff, W., Jones, P.J. & Clayton, R.N. (1996) The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism, 81, 1169-1172.
2. Bates, A.S., Bullivant, B., Clayton, R.N., Sheppard, M.C. & Stewart, P.M. (1999) Life expectancy following surgery for pituitary tumours. Clinical Endocrinology (Oxford), 50, 315-319.
3. Belcaro, G., Laurora, G. & Cesarone, M.R. (1993) Noninvasive ultrasonic biopsy: evaluation of early arteriosclerotic lesions progression in normal asymptomatic, hyperlipidemic and diabetic subjects. Angiology, 44, 93-99.
4. Beshyah, S.A. & Johnston, D. (1999) Cardiovascular disease and risk factors in adults with hypopituitarism. Clinical Endocrinology (Oxford), 50, 1-15.
5. Böger, R.H., Skamira, C., Bode-Böger, S.M., Brabant, C., Von Zur Muhlen, A. & Frolich, J.C. (1996) Nitric oxide mediates the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. Journal of Clinical Investigation, 98, 2706-2713.
6. Bonithon-Kopp, C., Touboul, P.-J., Berr, C., Berr, C., Leroux, C., Mainard, F., Bourbon, D. & Ducimetiere, P. (1996) Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The vascular aging (EVA) study. Arteriosclerosis, Thrombosis and Vascular Biology, 16, 310-316.
7. Borson-Chazot, F., Serusclat, A., Kalfallah, Y., Ducottet, X., Sassolas, G., Bernard, S., Labrousse, F., Pastene, J., Sassolas, A., Roux, Y. & Berthezéne, F. (1999) Decrease in carotid intima-media thickness after 1 year growth hormone (GH) treatment in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism, 84, 1329-1333.
8. Bülow, B., Hagmar, L., Mikoczy, Z., Nordstroem, C.H. & Erfurth, E.M. (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology (Oxford), 46, 75-81.
9. Bülow, B., Hagmar, L., Eskilsson, J. & Erfurth, E.M. (2000) Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. Journal of Clinical Endocrinology and Metabolism, 75, 574-584.
10. Capaldo, B., Patti, L., Oliviero, U., Longobardi, S., Pardo, F., Vitale, F., Fazio, S., Di Rella, F., Biondi, B., Lombardi, G. & Saccà, L. (1997) Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 82, 1378-1381.
11. Castelli, W.P. (1996) Lipid, risk factors and ischaemic heart disease. Atherosclerosis, 124, S1-S9.
12. Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr. Jones, D.W. Materson, B.L. Oparil, S. Wright, J.T. Jr. & Roccella, E.J. for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Journal of the American Medical Association, 289, 2560-2572.
13. Colao, A., Cerbone, G., Pivonello, R., Aimaretti, G., Loche, S., Di Somma, C., Faggiano, A., Corneli, G., Ghigo, E. & Lombardi, G. (1999a) The growth hormone (GH) response to arginine plus GH releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. Journal of Clinical Endocrinology and Metabolism, 84, 1277-1282.
14. Colao, A., Di Somma, C., Pivonello, R., Loche, S., Aimaretti, G., Cerbone, G., Faggiano, A., Corneli, G., Ghigo, E. & Lombardi, G. (1999b) Bone loss is correlated to the severity of growth hormone (GH) deficiency in adult patients with hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 84, 1919-1924.
15. Colao, A., Pivonello, P., Spiezia, S., Faggiano, A., Marzullo, P., Cerbone, G., Ferone, D., Filippella, M., Siciliani, M. & Lombardi, G. (1999c) Persistence of increased cardiovascular risk in patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 84, 2664-2672.
16. Colao, A., Di Somma, C., Cuocolo, A., Spinelli, L., Tedesco, N., Pivonello, R., Bonaduce, D., Salvatore, M. & Lombardi, G. (2001a) Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. Journal of Clinical Endocrinology & Metabolism, 86, 1874-1881.
17. Colao, A., Di Somma, C., Marzullo, P. & Lombardi, G. (2001b) Growth hormone and the heart. Clinical Endocrinology (Oxford), 54, 137-154.
18. Delafontaine, P., Lou, H. & Alexander, R.W. (1991) Regulation of insulin-like growth factor 1 messenger RNA levels in vascular smooth muscle cells. Hypertension, 18, 742-747.
19. Elhadd, T.A., Abdu, T.A., Oxtoby, J., Kennedy, G., McLaren, M., Neary, R., Belch, J.J.F. & Clayton, R.N. (2001) Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. Journal of Clinical Endocrinology and Metabolism, 86, 4223-4232.
20. Evans, L.M., Davies, J.S., Goodfellow, J., Rees, J.A.E. & Scanlon, M.F. (1999) Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clinical Endocrinology (Oxford), 50, 457-464.
21. Evans, L.M., Davies, J.S., Anderson, R.A., Ellis, G.R., Jackson, S.K., Lewis, M.J., Frenneaux, M.P., Rees, A. & Scanlon, M.F. (2000) The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. European Journal of Endocrinology, 142, 254-262.
22. Growth Hormone Research Society (GRS) (1998) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on adult growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 379-381.
23. Gryglewski, R.J., Palmer, R.M.J. & Moncada, S. (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 320, 454-456.
24. Janssen, J.A., Stolk, R.P., Pols, H.A., Grobbee, D.E. & Lamberts, S.W.J. (1998) Serum total IGF-I, free IGF-I and IGFBP-I levels in elderly population. Relation to cardiovascular risk factors and disease. Arteriosclerosis, Thrombosis and Vascular Biology, 18, 277-282.
25. Kvasnicka, J., Marek, J., Kvasnicka, T., Weiss, V., Markova, M., Stepan, J. & Umlaufova, A. (2000) Increase of adhesion molecules, fibrinogen, plasminogen activator inhibitor and orosomucoid in growth hormone deficient adults and its modulation by recombinant human GH replacement. Clinical Endocrinology (Oxford), 52, 543-548.
26. Lehmann, E.D., Hopkins, K.D., Weissberger, A.J., Gosling, R.G. & Sonksen, P.H. (1993) Aortic distensibility in growth hormone deficient adults. Lancet, 341, 309.
27. Markussis, V., Beshyah, S.A., Fisher, C., Sharp, P., Nicholaides, A.N. Johnston, D. (1992) Detection of premature atherosclerosis by high resolution ultrasonography in symptom free hypopituitary adults. Lancet, 340, 1188-1192.
28. Monson, J.P. (1997) The assessment of glucocorticoid replacement therapy. Clinical Endocrinology (Oxford), 46, 269-270.
29. Peacey, S.R., Guo, C.-U., Robinson, A.M., Price, A., Giles, M.A., Eastell, R. & Weetman, A.P. (1997) Glucocorticoid replacement therapy: are patients overtreated and does it matter? Clinical Endocrinology (Oxford), 46, 255-262.
30. Pearlman, B.L. (2002) The new cholesterol guidelines. Applying them in clinical practice. Postgraduate Medicine, 112, 13-16.
31. Pfeifer, M., Verhovec, R., Zizek, B., Prezelj, J., Poredos, P. & Clayton, R.N. (1999) Growth hormone treatment (GH) reverses early atherosclerotic changes in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 84, 453-457.
32. Rosen, T. & Bengtsson, B.-A. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285-288.
33. Simon, A., Gariepy, J., Chironi, G., Megnien, J.-L. & Levenson, J. (2002) Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. Journal of Hypertension, 20, 159-169.
34. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet, 354, 617-621.
35. Tomlinson, J.W., Holden, N., Hills, R., Wheatley, K., Clayton, R.N., Bates, A.S., Sheppard, M.C. & Stewart, P.M. (2001) Premature mortality in 1014 patients with hypopituitarism. Lancet, 357, 425-431.
36. Tsukahara, H., Gordienko, D.V., Tonshoff, B., Gelato, M.C. & Goligorsky, M.S. (1994) Direct demonstration of insulin-like growth factor I induced nitric oxide production by endothelial cells. Kidney International, 45, 598-604.
37. Walsh, F., Barazi, M., Pete, G., Muniyappa, R., Dunbar, J.C. & Sowers, J.R. (1996) Insulin-like growth factor-I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology, 137, 1798-1803.